Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
61 Cards in this Set
- Front
- Back
1. SRIF, DA and large doses of glucocorticoids inhibit _______________
|
a. TRH and therefore TSH release
|
|
1. Two main thyroid hormones
|
a. thyroxine or T4
b. triiodothyronine or T3 • they are iodinated derivatives of tyrosine. |
|
1. Uptake of iodine is stimulated by ________and inhibited by _________
|
a. Active transport system Stimulated by TSH
b. and Inhibited by ions • Iodide • Thiocyanate |
|
1. Iodide oxidized by ________to active form
|
a. thyroid peroxidase
• iodide has to be oxidized before it can be attached to tyrosyl residues in thyroglobulin |
|
1. thyroid hormone precursors:
|
a. monoiodotyrosine (MIT) and
b. diiodotyrosine (DIT) |
|
1. what thyroid hormone precursors make up T3
|
a. MIT + DIT = T3
|
|
1. what thyroid hormone precursors make up T4
|
a. DIT +DIT = T4
|
|
1. Where is T4 converted into T3
|
a. T4 is converted to T3 primarily in liver
• Chronic alcoholics cant convert T4T3 |
|
1. which thyroid hormone is more active…T3 or T4?
|
a. T3 is 5 times more active than T4
|
|
1. What enzyme is used to convert T4 into T3
|
a. 5'-deiodinase
• Enzyme found in liver, kidney and thyroid |
|
1. T4 and T3 transported bound to
|
a. thyroxine binding globulin (TBG)
• T4 binds to TBG with greater affinity • Binding to plasma proteins protects thyroid hormones from metabolism |
|
1. Metabolism and excretion of thyroid hormones occurs where?
|
a. Metabolized in liver
b. Excreted in feces |
|
1. Biological actions of thyroid hormone are mediated through___________
|
a. Mediated through nuclear T3 receptors
• Alter gene expression |
|
1. Function of thyroid hormone
|
a. Brain development & protein synthesis
b. Very important in the development of the fetus |
|
1. Cardiovascular effects of thyroid hormone
|
a.Increase heart rate,
b. Increase cardiac index, c.Decrease vascular resistance |
|
1. Thyroid hormone drugs include
|
a. Thyrotropin
b. thyrogen c. Levothyroxine d. Liothyronine e. Liotrix f. Thyroxine??? |
|
1. Thyrotropin is an analog to what hormone
|
a. TSH
• Bovine in nature • Used mostly for dx purposes |
|
1. Thyrogen is an analog to what hormone
|
a. Recombinant form of TSH
|
|
1. Levothyroxine is an analog to what hormone
|
a. T4
|
|
1. Liothyronine is an analog to what hormone
|
a. T3
|
|
1. Liotrix is an analog to what hormone
|
a. (combination of T4 and T3; 4:1)
|
|
1. Thyroxine is an analog to what hormone?
|
a. (T4) is drug of choice
• Longer duration of action • Most individuals (as long as their liver woks) giving T4 is enough |
|
1. 2 forms of TSH
|
a. Thyrotropin-- from bovine anterior pituitary
b. Thyrogen: --recombinant form of TSH |
|
1. Clinical use of TSH and its analogs
|
a. Hypothyroidism diagnosis
• --Differentiate between 1° and 2° hypothyroidism b. Thyroid carcinoma • --Enhances uptake of 131I by thyroid gland |
|
1. How is TSH used to differentiate between 1° and 2° hypothyroidism
|
a. If there is no elevation in T3 and T4 after you give TSH the problem is at the thyroid
b. If there is a elevation in T3 and T4 after you give TSH then the problem is the anterior pituitary |
|
1. Pharmicokinetics of TSH and its analog
|
a. IM or SC administration
b. Half-life: 35 minutes (both forms are short acting) c. Excreted in urine |
|
1. Adverse effects of TSH and its analog
|
a. Nausea/vomiting, headache, fever
b. Sinus tachycardia, atrial fibrillation • -----If you give this to a person with consistently low thyroid levels you will see cardiovascular effects • -----A spike in thyroid levels could irregular heart rates |
|
1. Contraindications of TSH and its analog
|
a. Coronary artery disease
b. Adrenal insufficiency |
|
1. Drug interactions of TSH and its analog
|
a. Sympathomimetics: additive effect
• -----Increase in rate and force of contraction (CV) • -----Increase cardiac output b. Hepatic enzyme inducers: • -----Barbiturates, rifampin, carbamazepine 1. ---------------TSH gets metabolized quicker if on these c. Estrogens increase levels of TBG |
|
1. Clinical use of T3 and T4
|
a. Hypothyroidism – replacement therapy
• T3 can be used when faster onset of action needed • T3 more expensive, requires frequent dosing • No advantages to using T3/T4 mixture b. Cretinism v. myxedema • Thyroid hormone in the fetal brain causes lots of neural migration • If you don’t have THYROID HORMONE IN FETAL BRAIN CREATISM • Mixedema can occur post partum in the developing brain if you have low thyroid hormone • Replacement of thyroid hormone reverses these effects c. TSH Suppression • Nodular thyroid disease • Diffuse goiters • Thyroid cancer |
|
1. What must happen to Levothyroxine before it becomes active?
|
a. Levothyroxine must be converted to T3 for clinical effect
|
|
1. Half Life of T3 and T4
|
a. T3-1day,
b. T4-7 days |
|
1. How long does it take T4 to achieve a steady state
|
a. 4-6 weeks
|
|
1. ROA for T3 and T4
|
a. Oral administration (~80% bioavailability)
• Metabolized in liver, excreted in feces • Children may require higher doses per Kg body weight |
|
1. Adverse effects of T3 and T4
|
a. Headache, insomnia, tremors, fever
b. Cardiac dysrhythmias, tachycardia c. Diarrhea, weight loss, amenorrhea |
|
1. Contraindications of T3 and T4
|
a. Adrenal insufficiency
b. Cardiac disease |
|
1. Drug interactions with T3 and T4
|
a. Warfarin: Increases anticoagulant activity
b. Bound by cholestyramine in GI tract • ----Also Al(OH)2 and FeSO4 (iron supplements) and sucralfate c. Drug interactions with TBG • Increase binding: estrogens, tamoxifen • Decrease binding: aspirin, phenytoin, furosemide, androgens, carbamazepine d. Hepatic enzyme inducers: • Barbiturates, rifampin, carbamazepine |
|
1. Antithyroid drug categories include
|
a. THIOUREYLENES
b. Iodide c. Iodinated contrast media |
|
1. THIOUREYLENE drugs include
|
a. Propylthiouracil (PTU)
b. Methimazole c. Carbimazole |
|
1. Iodide drugs include
|
a. Lugol’s solution
b. Potassium iodide |
|
1. Iodinated contrast media includes
|
a. Ipodate & iopanoic acid = oral administration
b. Diatrizoate = IV |
|
1. MOA of THIOUREYLENES
|
a. Inhibits thyroid peroxidase-mediated iodination (PRIMARY)
b. Inhibits coupling of MIT and DIT c. Inactivates oxidized form of thyroid peroxidase d. Propylthiouracil (PTU) inhibits peripheral conversion of T4 to T3 |
|
1. Clinical use of THIOUREYLENES
|
a. Hyperthyroidism
• Graves disease • Hyperfunctioning thyroid nodules • Thyroid storm ---------------Propylthiouracil drug of choice b. Treatment paradigms • Antithyroid drugs ---------------Treatment of choice during pregnancy • Drugs + radioactive iodine • Drugs + surgery |
|
1. ROA for THIOUREYLENES
|
a. Oral administration
|
|
1. THIOUREYLENES are actively concentrated where in the body
|
a. Actively concentrated in thyroid gland
|
|
1. Half life of THIOUREYLENES
|
a. PTU has shorter half-life (2 v. 7 hr), plasma protein bound
• Methimazole given once a day • Metabolized in liver, renal excretion |
|
1. ADVERSE EFFECTS THIOUREYLENES
|
a. Headache, vertigo, edema
b. N/V c. Rash: urticaria, pruritus, alopecia d. *Methimazole: agranulocytosis, aplastic anemia e. Reduces response to oral anticoagulants |
|
1. MOA of iodide
|
a. Inhibition of release of thyroid hormones
• Rapid effect • Action directly on thyroid gland b. Limits transport of iodide into thyroid c. Inhibits synthesis of MIT and DIT |
|
1. Clinical use of iodide
|
a. Hyperthyroidism
• Preoperative period in preparation for surgery • Thyroid storm |
|
1. ROA of iodide
|
a. Administered orally
• Lugol’s solution • Potassium iodide b. Rapid effect, accumulates in thyroid |
|
1. This antithyroid hormone develops tollerence after 2-3 days
|
a. iodide
|
|
1. Adverse effects of iodide
|
a. Nausea/vomiting, diarrhea
b. *Acneiform rash c. *Hypersensitivity (Type III) • Angioedema, hemorrhage d. *Induction of goiter and myxedema |
|
1. Drug interactions of iodide
|
a. Lithium
|
|
1. Components of IODINATED CONTRAST MEDIA
|
a. Ipodate & Iopanoic acid - Oral
b. Diatrizoate - IV |
|
1. Clinical use of iodinated contrast media
|
a. Hyperthyroidism
b. Inhibits conversion of T4 to T3 • (not approved by the FDA for this) • Euthyroid in 3 days • Suppresses T4 also • Inhibits release of hormones |
|
1. MOA of radioactive Iodide
|
a. Trapped by thyroid
b. Deposited in the follicle c. Acts almost exclusively on parenchymal cells d. ***Destroys thyroid w/o damage to surrounding tissue |
|
1. Clinical use of radioactive iodide
|
a. Hyperthyroidism
• Poor surgical subjects • Additional tx when subtotal thyroidectomy ineffective • Toxic nodular goiter |
|
1. ROA of radioactive iodide
|
a. oral
|
|
1. Half-life of radioactive iodide
|
a. 8 days
• 99% radiation lost w/I 56 days |
|
1. Adverse effects of radioactive iodide
|
a. High incidence of delayed hypothyroidism
b. Long tx period |
|
1. Contraindications of radioactive iodide
|
a. Pregnancy
|